- Home
- BTBT vs AGMB Comparison
BTBT vs AGMB Comparison
Compare BTBT & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTBT | AGMB |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 569.7M | 677.9M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | BTBT | AGMB |
|---|---|---|
| Price | $1.57 | $11.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $6.00 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 17.8M | 166.7K |
| Earning Date | 05-14-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $113,560,320.00 | N/A |
| Revenue This Year | $38.96 | N/A |
| Revenue Next Year | $89.41 | $17.86 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.10 | N/A |
| 52 Week Low | $1.25 | $9.00 |
| 52 Week High | $4.55 | $17.45 |
Technical Indicators
Market Signals| Indicator | BTBT | AGMB |
|---|---|---|
| Relative Strength Index (RSI) | 51.77 | 49.21 |
| Support Level | $1.53 | $9.82 |
| Resistance Level | $2.43 | $11.99 |
| Average True Range (ATR) | 0.10 | 0.94 |
| MACD | 0.03 | 0.20 |
| Stochastic Oscillator | 59.09 | 64.41 |
Price Performance
Historical ComparisonAbout BTBT Bit Digital Inc.
Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.
About AGMB AgomAb Therapeutics NV American Depositary Shares
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.